Keros Therapeutics Correlations
KROS Stock | USD 11.22 0.22 1.92% |
The current 90-days correlation between Keros Therapeutics and Ideaya Biosciences is 0.27 (i.e., Modest diversification). The correlation of Keros Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Keros Therapeutics Correlation With Market
Good diversification
The correlation between Keros Therapeutics and DJI is -0.02 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Keros Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Keros |
Moving together with Keros Stock
0.67 | CDIOW | Cardio Diagnostics | PairCorr |
0.71 | ELVN | Enliven Therapeutics | PairCorr |
0.61 | SCLX | Scilex Holding | PairCorr |
0.63 | ASMB | Assembly Biosciences Earnings Call This Week | PairCorr |
0.9 | CDIO | Cardio Diagnostics | PairCorr |
0.94 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.64 | MRK | Merck Company | PairCorr |
Moving against Keros Stock
0.88 | GE | GE Aerospace | PairCorr |
0.86 | PLX | Protalix Biotherapeutics | PairCorr |
0.73 | WM | Waste Management | PairCorr |
0.64 | LUCD | Lucid Diagnostics | PairCorr |
0.59 | MLSS | Milestone Scientific Earnings Call This Week | PairCorr |
0.89 | MMM | 3M Company | PairCorr |
0.76 | CVX | Chevron Corp | PairCorr |
0.74 | CSCO | Cisco Systems | PairCorr |
0.65 | IBM | International Business | PairCorr |
0.63 | JNJ | Johnson Johnson | PairCorr |
0.62 | T | ATT Inc Earnings Call Tomorrow | PairCorr |
0.6 | JPM | JPMorgan Chase | PairCorr |
0.55 | XOM | Exxon Mobil Corp | PairCorr |
0.41 | INTC | Intel | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Keros Stock performing well and Keros Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Keros Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
IDYA | 2.30 | (0.42) | 0.00 | (1.17) | 0.00 | 4.11 | 12.18 | |||
ANAB | 4.32 | 0.41 | 0.08 | 0.23 | 4.43 | 9.84 | 43.41 | |||
MGTX | 3.13 | 0.40 | 0.13 | (1.29) | 3.41 | 5.56 | 34.28 | |||
FIXX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
JANX | 2.83 | (0.91) | 0.00 | (0.72) | 0.00 | 8.08 | 20.17 | |||
FENC | 2.06 | 0.26 | 0.08 | 0.14 | 2.93 | 4.75 | 16.33 | |||
EWTX | 2.92 | (0.07) | 0.00 | (0.12) | 0.00 | 5.32 | 26.44 | |||
HRMY | 1.98 | 0.23 | 0.07 | 0.17 | 2.96 | 4.36 | 17.63 | |||
AVTE | 1.29 | 0.02 | 0.04 | 0.00 | 1.52 | 2.07 | 10.45 | |||
SNDX | 2.39 | 0.07 | 0.03 | 0.02 | 2.91 | 6.51 | 15.51 |
Keros Therapeutics Corporate Management
Robin Wagner | Senior Resources | Profile | |
Simon MBBS | Chief Officer | Profile | |
Keith MBA | Chief Officer | Profile | |
Christopher MSc | Chief Officer | Profile | |
John MBA | Senior Management | Profile | |
Jennifer Lachey | Chief Officer | Profile | |
Jasbir Seehra | CEO and President | Profile |